Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
scientific article published on 6 May 2014
Author/s
author: Kazuaki Chayama, Michio Imamura, Hiroshi Aikata, Tomokazu Kawaoka, Masataka Tsuge, Yoshiiku Kawakami, Akira Hiramatsu, Shoichi Takahashi, Hidenori Ochi, C Nelson Hayes, Takashi Nakahara, Hatsue Fujino, Atsushi Ono, Hiromi Kan, Tomoki Kobayashi, Takayuki Fukuhara, Yuko Nagaoki
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.